Fingerprint
Dive into the research topics of 'A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically